BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33558421)

  • 1. Outcomes of patients with cervical cancer treated with low- or high-dose rate brachytherapy after concurrent chemoradiation.
    Scott AA; Yarney J; Vanderpuye V; Akoto Aidoo C; Agyeman M; Boateng SN; Sasu E; Anarfi K; Obeng-Mensah T
    Int J Gynecol Cancer; 2021 May; 31(5):670-678. PubMed ID: 33558421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
    Petereit DG; Sarkaria JN; Potter DM; Schink JC
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
    Kim WC; Kim GE; Suh CO; Loh JJ
    Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens.
    Wong FC; Tung SY; Leung TW; Sze WK; Wong VY; Lui CM; Yuen KK; O SK
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1254-64. PubMed ID: 12654435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy.
    Chen SW; Liang JA; Yang SN; Ko HL; Lin FJ
    Radiother Oncol; 2003 Apr; 67(1):69-76. PubMed ID: 12758242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose-rate afterloading brachytherapy in carcinoma of the cervix: an experience of 1992 patients.
    Lorvidhaya V; Tonusin A; Changwiwit W; Chitapanarux I; Srisomboon J; Wanwilairat S; Chawapun N; Sukthomya V
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1185-91. PubMed ID: 10725630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
    Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent chemoradiation for cervical cancer: Comparison of LDR and HDR brachytherapy.
    Lin AJ; Samson P; Zoberi J; Garcia-Ramirez J; Williamson JF; Markovina S; Schwarz J; Grigsby PW
    Brachytherapy; 2019; 18(3):353-360. PubMed ID: 30971370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High versus low-dose rate brachytherapy for cervical cancer.
    Patankar SS; Tergas AI; Deutsch I; Burke WM; Hou JY; Ananth CV; Huang Y; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2015 Mar; 136(3):534-41. PubMed ID: 25575481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the efficacy and complication rates of low dose-rate versus high dose-rate brachytherapy in the treatment of uterine cervical carcinoma.
    Sarkaria JN; Petereit DG; Stitt JA; Hartman T; Chappell R; Thomadsen BR; Buchler DA; Fowler JF; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):75-82; discussion 247. PubMed ID: 8083131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
    Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
    Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
    Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical radiation therapy for adenocarcinoma of the uterine cervix.
    Toita T; Takizawa Y; Nakano M; Sueyama H; Kushi A; Kakihana Y; Ogawa K; Hara R; Higashi M; Sakumoto K
    Strahlenther Onkol; 1994 May; 170(5):277-80. PubMed ID: 8197550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-fraction HDR brachytherapy in locally advanced cervical cancer: A monocentric experience.
    Ogorodniitchouk O; Aunier J; Bousarsar A; Lahmamssi C; Sotton S; Ouaz H; Moreno-Acosta P; Moslemi D; Molekzadehmoghani M; Langrand-Escure J; Magne N; Vallard A
    Cancer Radiother; 2021 Jul; 25(5):463-468. PubMed ID: 34023215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
    Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
    Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R
    Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brachytherapy for stage IIIB squamous cell carcinoma of the uterine cervix: survival and toxicity.
    Zuliani AC; Cunha Mde O; Esteves SC; Teixeira JC
    Rev Assoc Med Bras (1992); 2010; 56(1):37-40. PubMed ID: 20339784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study.
    Tacev T; Vacek A; Ptácková B; Strnad V
    Strahlenther Onkol; 2005 May; 181(5):273-84. PubMed ID: 15900423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.